Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: J Urol. 2008 Jun 11;180(2):539–543. doi: 10.1016/j.juro.2008.04.015

Table 2.

Comparison of mean serum values for the non-cancer and cancer groups for subjects in the 2-10 ng/mL PSA range (n=89)

Non-Cancer Cancer p-value
Mean±SD Median N Mean±SD Median N ns
PSA, ng/mL 5.82±2.02 5.49 39 5.60±2.01 5.41 50 ns
Free PSA, ng/mL 0.92±0.460 0.84 39 0.82±0.42 0.80 50 ns
[-2]proPSA, pg/mL 9.31±4.52 7.40 39 11.97±6.38 10.09 50 0.03
BPSA, pg/mL 289.1±273.6 216.5 38 224.0±149.2 197.9 49 ns
%fPSA 16.4±6.82 15.4 39 15.6±6.89 15.2 50 ns
%[-2]proPSA 1.10±0.43 1.08 39 1.53±0.53 1.47 50 0.0001
%BPSA 30.3±20.7 23.3 39 27.4±13.49 25.1 49 ns
[-2]proPSA/BPSA 0.050±0.03 0.045 39 0.069±0.040 0.063 49 0.02
Testosterone, ng/mL 3.92±1.21 3.72 34 3.83±1.38 3.70 47 ns

ns: not significant